Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (101-110 of 231) with videos related to

Pageof 24
Sort By:
Multiple Sclerosis and Related Disorders|May 27, 2025
Influence of oral and skin microbiota on multiple sclerosis risk and severity: A mendelian randomization analysisValeria Zancan, Martina Nasello, Selene Diamant, et al.
Plos One|March 21, 2020
Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosisRuggiero Seccia, Daniele Gammelli, Fabio Dominici, et al.
International Journal of Molecular Sciences|May 25, 2024
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World ExperienceMartina Nasello, Valeria Zancan, Virginia Rinaldi, et al.
Journal of Neurology|December 12, 2024
Spasticity patterns assessment and recognition for therapeutic approaches (SPARTA) in multiple sclerosis: a multicenter epidemiological studyPaolo De Blasiis, Andrea Massimiani, Cristina Inglese, et al.
Journal of Neurology|February 27, 2021
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-upLaura Fionda, Antonella Di Pasquale, Stefania Morino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patientsElena Giacomini, Fabiana Rizzo, Marilena P Etna, et al.
Frontiers in Neurology|December 19, 2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic reviewVirginia Rinaldi, Gianmarco Bellucci, Maria Chiara Buscarinu, et al.
Annali Dell'Istituto Superiore Di Sanita|October 26, 2005
Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up studyAndrea Visconti, Rodolfo Cotichini, Stefania Cannoni, et al.
Frontiers in Immunology|October 14, 2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2013
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodologyGiancarlo Comi, Mario Alberto Battaglia, Antonio Bertolotto, et al.
Pageof 24

Showing results (101-110 of 231) with videos related to

Sort By:
Pageof 24
Multiple Sclerosis and Related Disorders|May 27, 2025
Influence of oral and skin microbiota on multiple sclerosis risk and severity: A mendelian randomization analysisValeria Zancan, Martina Nasello, Selene Diamant, et al.
Plos One|March 21, 2020
Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosisRuggiero Seccia, Daniele Gammelli, Fabio Dominici, et al.
International Journal of Molecular Sciences|May 25, 2024
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World ExperienceMartina Nasello, Valeria Zancan, Virginia Rinaldi, et al.
Journal of Neurology|December 12, 2024
Spasticity patterns assessment and recognition for therapeutic approaches (SPARTA) in multiple sclerosis: a multicenter epidemiological studyPaolo De Blasiis, Andrea Massimiani, Cristina Inglese, et al.
Journal of Neurology|February 27, 2021
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-upLaura Fionda, Antonella Di Pasquale, Stefania Morino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patientsElena Giacomini, Fabiana Rizzo, Marilena P Etna, et al.
Frontiers in Neurology|December 19, 2022
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic reviewVirginia Rinaldi, Gianmarco Bellucci, Maria Chiara Buscarinu, et al.
Annali Dell'Istituto Superiore Di Sanita|October 26, 2005
Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up studyAndrea Visconti, Rodolfo Cotichini, Stefania Cannoni, et al.
Frontiers in Immunology|October 14, 2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2013
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodologyGiancarlo Comi, Mario Alberto Battaglia, Antonio Bertolotto, et al.
Pageof 24